Current Market Update

Here are the latest trading levels for Asia's major stock markets: 


Tokyo (Nikkei Average) up 1.3% 

 Hong Kong (Hang Seng Index) flat 

 Shanghai (Shanghai Composite Index) up 1% (at break) 

 Sydney (S&P/ASX 200) down 0.4% 

 Seoul (Kospi) down 0.1% 

 Mumbai (Sensex) up 1.8% 

 Taipei (Taiex) flat

KLSE Malaysia Opening Market Update

MALAYSIA share prices opened higher on Thursday with the FTSE Bursa Malaysia Kuala Lumpur Composite Index up 6.26 points to 1747.54.

Volume was 43 million lots worth RM31.89 million.

Gainers outnumbered losers 88 to 69.

Market Closing Update

MALAYSIAN shares ended lower on Wednesday with the Kuala Lumpur Composite Index slipping 6.89 points to close at 1,742.01.

Some 1.8 billion lots, valued at RM2.49 billion were traded. Gainers numbered 450 while losers numbered 349.

KLSE IForex Recommendations

TRADING TIPS :

GBP/USD touching lows of 1.5078 after data on Tuesday showing the annual rate of U.K. inflation rose at the slowest rate since May 2000 in December.Official figures showed that annual rate of consumer inflation in the U.K. slowed to 0.5% last month, underlining expectations that the Bank of England will keep rates on hold this year.The annual rate of consumer inflation slowed to 0.5% last month the Office of National Statistics said, down from 1.0% in November. It was the lowest rate of inflation since May 2000. Economists had expected a smaller decline to 0.7%.Consumer prices were unchanged month-on-month, compared to expectations for a reading of 0.1% after falling 0.3% in November.

INTRADAY OUTLOOK
Support: 1.5116
Resistance: 1.5193

RECOMMENDATION:
1. Buy GBP/USD Above 1.5195-TG: 1.5215/1.5235 SL 1.5165
2. Sell GBP/USD Below 1.5114-TG: 1.5094/1.5064 SL 1.5144

INTRADAY OUTLOOK
Immediate Support: 1.1746
Immediate Resistance: 1.1805

RECOMMENDATION:
1. Buy EUR/USD Above -1.1807 TG: 1.1827/1.1857 SL 1.1777
2. Sell EUR/USD Below -1.1744 TG:1.1724/1.1694 SL 1.1777

KLSE Stock Recommendations

MARKET UPDATES :

Malaysian Biotechnology Corp (BiotechCorp) aims to reap RM2 billion in revenue from 248 BioNexus-status companies in 2015, its Chief Executive Officer, Datuk Dr Mohd Nazlee Kamal said.These companies generated revenue of RM1.4 billion in 2014 from RM1.169 billion in 2013.BioNexus is a special status awarded to qualified international and Malaysian biotech companies that qualify for fiscal incentives, grants and guarantees administered by BiotechCorp.




STOCK RECOMMENDATION :

BUY V.S INDUSTRY ABOVE 2.860 TARGET 2.900 2.960 SL 2.800